DMS announced 23 June that it was in negotiations, on an exclusive basis, with two funds (Jolt Capital and Ambrosia Invesments) with a view to selling its stake in Alpha Mos (42.94% of equity and 49.94% of voting rights) for €0.45 per share or €6.5m. On the evening of 27 June, the group announced that the deal had been finalised.

27 Jun 2017
Selling the stake in Alpha Mos

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Selling the stake in Alpha Mos
Diagnostic Medical Systems (0RIA:LON) | 0 0 0.0%
- Published:
27 Jun 2017 -
Author:
Fabrice Farigoule -
Pages:
2 -
DMS announced 23 June that it was in negotiations, on an exclusive basis, with two funds (Jolt Capital and Ambrosia Invesments) with a view to selling its stake in Alpha Mos (42.94% of equity and 49.94% of voting rights) for €0.45 per share or €6.5m. On the evening of 27 June, the group announced that the deal had been finalised.